Hubbell Total Cost of Revenue increased by 4.5% to $1.01B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.6%, from $922.60M to $1.01B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 5.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $756.00M | $782.30M | $810.20M | $833.00M | $872.80M | $917.70M | $852.80M | $837.10M | $869.70M | $888.40M | $900.70M | $965.50M | $938.70M | $936.60M | $882.10M | $922.60M | $932.20M | $958.10M | $967.60M | $1.01B |
| QoQ Change | — | +3.5% | +3.6% | +2.8% | +4.8% | +5.1% | -7.1% | -1.8% | +3.9% | +2.2% | +1.4% | +7.2% | -2.8% | -0.2% | -5.8% | +4.6% | +1.0% | +2.8% | +1.0% | +4.5% |
| YoY Change | — | — | — | — | +15.4% | +17.3% | +5.3% | +0.5% | -0.4% | -3.2% | +5.6% | +15.3% | +7.9% | +5.4% | -2.1% | -4.4% | -0.7% | +2.3% | +9.7% | +9.6% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Utility Solutions | $576.20M | $597.60M | $602.80M | $619.70M | $631.80M |
| Electrical Solutions | $337.80M | $334.60M | $355.30M | $356.50M | $379.60M |
| Total | $922.60M | $932.20M | $958.10M | $967.60M | $1.01B |